Biocon (NSE:BIOCON) Inventories, Finished Goods: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOCON Biocon Ltd NSE:BIOCON
88 GF Score
Price ₹411.10
GF Value ₹332.39
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Biocon Inventories, Finished Goods?

Biocon NSE:BIOCON -1.74% 88 Inventories, Finished Goods is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:BIOCON with a GF Score™ of 88/100 and a GF Value™ of ₹332.39 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Biocon's quarterly finished goods increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹21,069 Mil) but then declined from Mar. 2026 (₹21,069 Mil) to Jun. 2026 (₹0 Mil).

Biocon's annual finished goods declined from Mar. 2024 (₹24,129 Mil) to Mar. 2025 (₹18,101 Mil) but then increased from Mar. 2025 (₹18,101 Mil) to Mar. 2026 (₹21,069 Mil).

Biocon Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Biocon's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biocon Inventories, Finished Goods Chart

Biocon Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,801.00 15,996.00 24,129.00 18,101.00 21,069.00

Biocon Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 21,069.00 0.00
NSE:BIOCON
88GF Score
Biocon Ltd NSE:BIOCON
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biocon Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹0 Mil mean?
Biocon (NSE:BIOCON) has a Inventories, Finished Goods of ₹0 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Biocon and its competitors.
Is Biocon's Inventories, Finished Goods too high?
Biocon's current Inventories, Finished Goods is ₹0 Mil. Overall, Biocon has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biocon's Inventories, Finished Goods compare to VRTX and REGN?
Biocon's Inventories, Finished Goods of ₹0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Biocon and its competitors. Biocon's current Inventories, Finished Goods is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biocon stock overvalued right now?
Based on GuruFocus' analysis, Biocon (NSE:BIOCON) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹332.39, compared to a current price of ₹411.10 — trading 23.7% above its estimated fair value. The current Inventories, Finished Goods is ₹0 Mil. Biocon's overall GF Score™ is 88/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Biocon (NSE:BIOCON), the current Inventories, Finished Goods is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biocon (NSE:BIOCON) Overvalued in 2026?

Based on GuruFocus' analysis, Biocon stock appears to be overvalued. The current stock price of ₹411.10 is trading 23.7% above its estimated GF Value™ of ₹332.39. GuruFocus considers Biocon to be Modestly Overvalued.

Key valuation signals for NSE:BIOCON:

  • Inventories, Finished Goods: ₹0 Mil
  • GF Value™: ₹332.39 vs. price of ₹411.10 (23.7% above fair value)
  • GF Score™: 88/100 with 9 warning signs

No single metric tells the full story. See the NSE:BIOCON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biocon Business Description

Other Exchanges 532523:India
Address 20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.
88GF Score

Get the complete analysis for NSE:BIOCON

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹411.10
Price
₹332.39
GF Value